Psoriasis is a condition where light therapy is genuinely established treatment, which makes it unusually important to be clear about which light, because the answer is not the one we sell.
What psoriasis is
Psoriasis is an immune-mediated condition in which skin cells turn over far too quickly, producing raised, scaly plaques.
Normal skin cells take around a month to travel from the base of the epidermis to the surface. In psoriasis that takes days. Cells arrive before they have matured and pile up, producing the thickened, silvery-scaled plaques that characterise it.
The driver is immune, not cosmetic. Psoriasis is also associated with psoriatic arthritis and with cardiovascular risk, which is part of why it warrants proper medical management rather than being treated as a skin nuisance.
The established light treatment
Established light treatment for psoriasis is narrowband ultraviolet B, delivered under dermatological supervision, which is a different part of the spectrum from red and near-infrared.
Narrowband UVB, typically around 311 nm, has decades of evidence and appears in treatment guidelines worldwide. It works by suppressing the overactive immune activity in the skin, which is a completely different mechanism from photobiomodulation.
It is delivered in dermatology departments with measured dosing and monitoring, because UV carries cumulative skin cancer risk that has to be tracked against benefit. That supervision is a feature, not bureaucracy.
What the red light research shows
Research into red and near-infrared light for psoriasis is smaller and more preliminary.
A handful of studies report reduced plaque thickness, scaling and redness after several weeks of treatment.
The appeal is real and worth stating: it avoids the ultraviolet exposure and associated skin cancer risk that limits UVB. UVB treatment is limited by lifetime dose, so patients cannot simply continue indefinitely. A treatment without that ceiling would be genuinely useful, particularly for a lifelong condition.
But the evidence is not yet strong enough to consider it an alternative to established treatment. A handful of studies is a reason to keep researching, not a reason to switch.
What we would say to someone with psoriasis
Psoriasis is a long-term medical condition and is best managed with a dermatologist who can weigh the options.
Treatment has changed enormously. Beyond topicals and phototherapy, biologic drugs targeting specific immune pathways can produce near-complete clearance for people with moderate to severe disease. Anyone whose picture of psoriasis treatment is coal tar and steroid cream may be years out of date.
A dermatologist can also assess whether joint symptoms suggest psoriatic arthritis, which needs treating early because joint damage does not reverse.
If you use light therapy alongside
- Alongside, not instead. Continue whatever your dermatologist has prescribed
- Tell them. Especially if you are having UVB phototherapy, so nothing is duplicated or confused
- Clean, bare skin. Thick emollients and ointments block light. Apply them afterwards
- Ten to twenty minutes over affected areas, three to five times a week
- Give it several weeks, which is the timescale the studies used
- Watch for the Koebner phenomenon. Psoriasis can appear at sites of skin trauma, so avoid anything that irritates or overheats plaques
- Keep moisturising. Barrier care remains basic and effective
When to see a doctor
See a dermatologist if psoriasis covers a significant area, is not responding to current treatment, affects your scalp, nails, face or genitals, is causing distress, or if you have joint pain, stiffness or swelling, which may indicate psoriatic arthritis.
Sudden widespread psoriasis, or psoriasis with fever and feeling unwell, needs urgent assessment, as rare severe forms exist.
Common questions
Does red light therapy help psoriasis? A handful of studies report reduced plaque thickness, scaling and redness after several weeks. The evidence is not yet strong enough to consider it an alternative to established treatment.
Is it the same as UVB phototherapy? No. Narrowband UVB is the established treatment, uses ultraviolet, and is delivered under dermatological supervision.
What is the advantage of red light? It avoids ultraviolet exposure and the associated skin cancer risk that limits how much UVB anyone can have.
Can it replace my treatment? No. Continue what your dermatologist has prescribed and tell them what you are adding.
How long before I see anything? Studies ran several weeks.
Where to start
Speak to your dermatologist first. If they are comfortable with it, a targeted panel suits localised plaques and a larger system suits widespread involvement.
Browse our Future Form systems, or read more on eczema, where the same UVB distinction applies, and inflammation. Free worldwide shipping, all import duties included.
